Literature DB >> 31273434

Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer.

Andrei Gafita1, Hui Wang2, Robert Tauber3, Calogero D'Alessandria2, Wolfgang A Weber2, Matthias Eiber2.   

Abstract

Entities:  

Year:  2019        PMID： 31273434     DOI： 10.1007/s00259-019-04410-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT.

Authors:  Andrei Gafita; Marie Bieth; Markus Krönke; Giles Tetteh; Fernando Navarro; Hui Wang; Elisabeth Günther; Bjoern Menze; Wolfgang A Weber; Matthias Eiber
Journal:  J Nucl Med       Date:  2019-03-08       Impact factor: 10.057

2.  [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.

Authors:  Michael S Hofman; John Violet; Rodney J Hicks; Justin Ferdinandus; Sue Ping Thang; Tim Akhurst; Amir Iravani; Grace Kong; Aravind Ravi Kumar; Declan G Murphy; Peter Eu; Price Jackson; Mark Scalzo; Scott G Williams; Shahneen Sandhu
Journal:  Lancet Oncol       Date:  2018-05-08       Impact factor: 41.316

3.  Early Experience of Rechallenge 177Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer.

Authors:  Andrei Gafita; Isabel Rauscher; Margitta Retz; Karina Knorr; Matthias Heck; Hans-Jürgen Wester; Calogero D'Alessandria; Wolfgang A Weber; Matthias Eiber; Robert Tauber
Journal:  J Nucl Med       Date:  2018-11-15       Impact factor: 10.057

4.  Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.

Authors:  Pedro Isaacsson Velho; Fahad Qazi; Sayeedul Hassan; Michael A Carducci; Samuel R Denmeade; Mark C Markowski; Daniel L Thorek; Theodore L DeWeese; Daniel Y Song; Phuoc T Tran; Mario A Eisenberger; Emmanuel S Antonarakis
Journal:  Eur Urol       Date:  2018-10-04       Impact factor: 20.096

5.  Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Authors:  Colin C Pritchard; Joaquin Mateo; Michael F Walsh; Navonil De Sarkar; Wassim Abida; Himisha Beltran; Andrea Garofalo; Roman Gulati; Suzanne Carreira; Rosalind Eeles; Olivier Elemento; Mark A Rubin; Dan Robinson; Robert Lonigro; Maha Hussain; Arul Chinnaiyan; Jake Vinson; Julie Filipenko; Levi Garraway; Mary-Ellen Taplin; Saud AlDubayan; G Celine Han; Mallory Beightol; Colm Morrissey; Belinda Nghiem; Heather H Cheng; Bruce Montgomery; Tom Walsh; Silvia Casadei; Michael Berger; Liying Zhang; Ahmet Zehir; Joseph Vijai; Howard I Scher; Charles Sawyers; Nikolaus Schultz; Philip W Kantoff; David Solit; Mark Robson; Eliezer M Van Allen; Kenneth Offit; Johann de Bono; Peter S Nelson
Journal:  N Engl J Med       Date:  2016-07-06       Impact factor: 91.245
  5 in total
  1 in total

1.  The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer-a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report.

Authors:  Masha Maharaj; Lucille Heslop; Trisha Govender; Nisaar Korowlay; Aviral Singh; Partha Choudhary; Mike Sathekge
Journal:  Nucl Med Mol Imaging       Date:  2021-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.